Is 10X Genomics Inc (TXG) a risky stock?
As of July 27, 2026, Clavix grades 10X Genomics Inc (TXG) D+ for risk, a composite score of 48 out of 100 on an A+ to F scale, which puts TXG in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
TXG price, last 3 months
TXG's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind TXG's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how TXG scores on each, as of July 27, 2026.
What's moving TXG's risk right now
Company-specific signals Clavix flags behind TXG's current grade, drawn from recent news and filings as of July 27, 2026.
Following a sharp 209.7% gain, TXG shares offer limited upside based on cash flow analysis and trade at premium multiples, suggesting the stock's strong run may already be priced…
The removal from value indexes signals that Russell classifies TXG more as a growth stock than a value stock, which could reduce demand from value-focused institutional investors…
Recent TXG news
The latest headlines Clavix ingested for 10X Genomics Inc, newest first. These feed the news-sentiment dimension of TXG's grade.
-
10x Genomics (Nasdaq: TXG) announced it will report its second quarter 2026 financial results (quarter ended June 30, 2026) after market close on August 6, 2026. The article body is truncated and provides no additional financial details.
-
Canaccord Genuity Group raised its price target on 10x Genomics (NASDAQ:TXG) from $32.00 to $50.00, representing a 56% increase, and assigned the stock a 'buy' rating in a research note issued on Tuesday.
What a D+ grade means
On the Clavix A+ to F scale, TXG's composite of 48 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell TXG or any security. Grades are risk indicators, not predictions of return. Data may be delayed.